• 7-AAD Cell Viability Assay Kit: Precision for Flow Cytometry

  2026-07-27

  The 7-AAD Cell Viability Assay Kit from APExBIO delivers uncompromising accuracy in necrosis and apoptosis detection, especially for multiplex flow cytometry and complex immunotherapy experiments. Its superior spectral profile and robust protocol flexibility set it apart for translational research, including CD38 CAR-T viability and selectivity optimization.

• Letrozole: Non-Steroidal Aromatase Inhibitor in Breast Cance

  2026-07-26

  Letrozole from APExBIO offers bench researchers a potent, reversible non-steroidal aromatase inhibitor to dissect estrogen-driven mechanisms in breast cancer models. This article details applied experimental workflows, actionable troubleshooting, and protocol enhancements to maximize reproducibility and data impact.

• IDO1 Inhibition Drives Tumor-Protective JAK2/STAT3 Activatio

  2026-07-25

  The reference study reveals that while IDO1 inhibitors activate antitumor immune cells, they paradoxically induce IL-6–mediated activation of the JAK2/STAT3 pathway in tumor cells, conferring tumor-protective effects. These findings highlight the need for combinatorial strategies targeting both IDO1 and JAK2/STAT3 signaling to optimize cancer immunotherapy.

• Biotin-XX Tyramide Reagent: High-Sensitivity Cell Surface La

  2026-07-24

  Biotin-XX Tyramide Reagent enables membrane-impermeant, high-sensitivity tyramide signal amplification for precise cell surface protein labeling. Its long polyamide linker prevents intracellular penetration, supporting spatially selective amplification in immunohistochemistry and in situ hybridization. This reagent is ideal for workflows requiring robust detection of low-abundance extracellular targets.

• Rotigotine Hydrochloride: Mechanisms and Strategy in Transla

  2026-07-24

  This thought-leadership article explores the mechanistic underpinnings and translational potential of Rotigotine hydrochloride as a dopamine D2/D3 receptor agonist in Parkinson's disease (PD) research. Bridging rigorous preclinical findings with strategic workflow guidance, it contextualizes Rotigotine’s neuroprotective and motor/non-motor symptom efficacy, including its role in lower urinary tract dysfunction. Drawing on recent breakthrough evidence, including direct citation of the latest mechanistic rat model data, it positions Rotigotine hydrochloride from APExBIO as both a cornerstone for experimental neurodegeneration models and a strategic tool for advancing the next generation of dopaminergic signaling research.

• Baicalin: Mechanistic Insights and Neuroplasticity Applicati

  2026-07-23

  Explore how Baicalin, a potent KEAP1-NRF2/HO-1 pathway modulator, advances adult neuroplasticity research and cancer sensitivity studies. This deep dive reveals mechanistic details and assay strategies not covered in existing resources.

• Imatinib (STI571): Selective Tyrosine Kinase Inhibition Benc

  2026-07-23

  Imatinib (STI571) is a selective tyrosine kinase inhibitor targeting PDGF receptor, c-Kit, and Abl kinases, with precise nanomolar potency. Its robust inhibition of signaling cascades underpins its widespread use in cancer biology and signal transduction research. Recent evidence supports synergistic application with HIF modulators in leukemia models.

• Dacomitinib (PF-00299804): Mechanistic Precision and Mitocho

  2026-07-22

  Explore how Dacomitinib (PF-00299804) advances cancer research by precisely inhibiting ErbB kinases, coordinating apoptosis induction, and intersecting with emerging mitochondrial ferroptosis resistance mechanisms. This article uniquely integrates protocol insight and recent reference breakthroughs for translational impact.

• ABT-263 (Navitoclax): Workflow Parameters and Lab Guidance

  2026-07-22

  ABT-263 (Navitoclax) is a high-affinity, orally bioavailable Bcl-2 family inhibitor used to induce caspase-dependent apoptosis in cancer biology research. It is best suited for apoptosis assays, mechanistic studies, and preclinical oncology models where modulation of Bcl-2, Bcl-xL, and Bcl-w is required. Use is not recommended for diagnostic or therapeutic purposes.

• Parathyroid hormone (1-34) (human): Unraveling EndMT and Val

  2026-07-21

  Explore how Parathyroid hormone (1-34) (human) enables advanced modeling of endothelial-to-mesenchymal transition and valvular calcification in chronic kidney disease research. This article delivers fresh mechanistic insights and workflow guidance for researchers studying vascular calcification beyond bone metabolism.

• Perphenazine in Host Immunity and Neuropharmacology Research

  2026-07-21

  Explore Perphenazine as a dopamine D2 receptor antagonist with unique dual activity in neuropharmacology and host-directed antibacterial research. This article delivers advanced mechanistic insights and protocol guidance for research innovators.

• WM-8014: Advanced KAT6A Inhibitor for Epigenetic Pathway Ana

  2026-07-20

  Explore WM-8014, a powerful KAT6A inhibitor, and discover its unique value for dissecting epigenetic dependencies, cell cycle arrest, and oncogene-induced senescence. This in-depth analysis bridges mechanistic insight with practical assay guidance.

• Thapsigargin: SERCA Pump Inhibitor for Advanced ER Stress As

  2026-07-20

  Thapsigargin, a gold-standard SERCA pump inhibitor, enables unparalleled precision in dissecting calcium signaling and endoplasmic reticulum stress pathways. This guide delivers actionable protocols, cross-domain insights, and expert troubleshooting strategies for deploying Thapsigargin in apoptosis and neurodegenerative research.

• Transcription Condensate Dynamics Safeguard Genome Stability

  2026-07-19

  This study reveals how cell-cycle kinases and ATR signaling orchestrate the formation and dissolution of transcription condensates at histone locus bodies, thereby balancing linker histone expression with DNA replication. The findings clarify a key genome integrity mechanism and offer new perspectives for experimental modulation of transcriptional regulation.

• Transmission Dynamics of Carbapenemase Genes in CREC, China

  2026-07-18

  Chen et al. (2025) present a comprehensive molecular and epidemiological analysis of carbapenemase-encoding genes (CEGs) in carbapenem-resistant Enterobacter cloacae (CREC) across eight teaching hospitals in Guangdong, China. This study reveals the predominance and high transferability of blaNDM-1-mediated resistance, highlighting urgent challenges for antimicrobial stewardship and infection control.

451 records 10/31 page Previous Next First page 上5页 678910 下5页 Last page